170 related articles for article (PubMed ID: 21953704)
1. Ecstasy use and self-reported disturbances in sleep.
Ogeil RP; Rajaratnam SM; Phillips JG; Redman JR; Broadbear JH
Hum Psychopharmacol; 2011 Oct; 26(7):508-16. PubMed ID: 21953704
[TBL] [Abstract][Full Text] [Related]
2. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
Ogeil RP; Rajaratnam SM; Broadbear JH
Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.
Pirona A; Morgan MJ
J Psychopharmacol; 2010 Feb; 24(2):175-85. PubMed ID: 19351799
[TBL] [Abstract][Full Text] [Related]
4. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.
Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ
J Psychopharmacol; 2009 May; 23(3):249-57. PubMed ID: 18562419
[TBL] [Abstract][Full Text] [Related]
5. Self reported sleep quality and cognitive performance in ecstasy users.
Montgomery C; Fisk JE; Wareing M; Murphy P
Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
[TBL] [Abstract][Full Text] [Related]
6. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
Fisk JE; Montgomery C; Murphy PN
Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
[TBL] [Abstract][Full Text] [Related]
7. Is emotional intelligence impaired in ecstasy-polydrug users?
Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
[TBL] [Abstract][Full Text] [Related]
8. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
Sumnall HR; Cole JC; Jerome L
J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
[TBL] [Abstract][Full Text] [Related]
9. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
10. Modelling the adverse effects associated with ecstasy use.
Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
12. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
Huxster JK; Pirona A; Morgan MJ
J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
14. Everyday memory deficits in ecstasy-polydrug users.
Montgomery C; Fisk JE
J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
[TBL] [Abstract][Full Text] [Related]
15. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
16. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
Medina KL; Shear PK; Corcoran K
J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
[TBL] [Abstract][Full Text] [Related]
17. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
Engels RC; ter Bogt T
Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
[TBL] [Abstract][Full Text] [Related]
18. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
Yen CF; Hsu SY; Cheng CP
Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
[TBL] [Abstract][Full Text] [Related]
19. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
Soar K; Parrott A; Turner J
J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
[TBL] [Abstract][Full Text] [Related]
20. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
Matthews AJ; Bruno R
Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
